At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 1 of this podcast series features exclusive conversations on machine learning for myelodysplastic syndromes risk prognostication, ways to reduce the use of stigmatizing language in the electronic medical record, ethical concerns surrounding AI in cancer care, efforts to create a more equitable blood donation and transfusion system, and much more!

Oncology Data Advisor at the American Society of Hematology (ASH) 2023: Part 1

In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Adrian Mosquera, Clinical Hematologist at the University Hospital of Santiago de Compostela, about his research team’s novel machine learning model that incorporates patient characteristics and histological subtype into risk prognostication for mantle cell lymphoma (MCL). In addition, Dr. Mosquera shares more of his research utilizing artificial intelligence for designing more risk-tailored therapeutic approaches and facilitate personalized medicine in hematologic malignancies.

Harnessing Machine Learning for MCL Risk Prognostication With Adrian Mosquera, MD, PhD

At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. This podcast series features exclusive conversations on breaking data for novel therapies, technological innovations in hematology/oncology, efforts to reduce disparities and improve health equity, and more!

Maintaining Functioning and QOL With Odronextamab for Follicular Lymphoma: Benoit Tessoulin, MD

Financial Hardship Experienced During Transplant in Myelodysplastic Syndromes: Christopher Su, MD

Evaluating Outpatient Teclistamab Administration in Multiple Myeloma: Robert Rifkin, MD

Investigating CD19-Targeted CAR T Cells for Autoimmune Diseases: Fabian Mueller, MD

Advancing Inclusion for Blood Donation Systems for Marginalized Groups: Warren Fingrut, MD

Lowering Talquetamab Dosing Intensity to Improve Tolerability: Ajai Chari, MD

Addressing Ethical Concerns Around Artificial Intelligence in Cancer Care: Andrew Hantel, MD

Expanding Access to Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Andre Goy, MD

Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Oncology Data Advisor at the American Society of Hematology (ASH) 2023: Part 1

Oncology Data Advisor®